The therapeutic effects of Spt4 or Supt4h inhibition in reducing the transcription of CAG repeats in Huntington’s disease [89], has raised the possibility that inhibiting the Spt4 or Supt4h may be beneficial in other diseases with repeat expansion mutations. The gene discussed is SUPT4H1; the disease is Huntington disease.